Patients with rheumatoid arthritis (RA) who used GLP-1 receptor agonists had less disease activity and improved ...

GLP-1 receptor agonists may reduce the likelihood of mortality and increase odds for transplant wait-listing for patients ...

Beyond GLP-1 RA prescriptions, chronic kidney disease (CKD) patients require comprehensive care from doctors, dietitians, & ...

Lung cancer patients who take medications called GLP-1 receptor agonists—commonly prescribed for weight loss and diabetes ...

Patients with heart failure using glucagon-like peptide 1 receptor agonists (GLP-1 RAs) have less carbon dioxide equivalent (CO2e) greenhouse gas (GHG) emissions per patient per year.

GLP-1 receptor agonists vs other second-line therapies were not associated with an increased thyroid cancer risk among patients with type 2 diabetes.

By Dr. Liji Thomas, MD New national data reveal a sharp rise in GLP-1 prescriptions for young women, but low contraception ...

GLP-1 drugs have been in the news a lot lately. Most recently, Serena Williams went public about taking GLP-1s as part of her weight loss journey. In a nutshell, GLP-1s are a trending topic—and one ...

GLP-1 medications like Ozempic show promise for multiple health conditions, as experts explore microdosing benefits for blood sugar control and longevity.

More than 14.0% of women, those undergoing sleeve gastrectomy, and those with type 2 diabetes initiated GLP-1 RAs after bariatric surgery. HealthDay News — Fourteen percent of individuals initiate ...

Semaglutide is linked to significant weight loss and glucose levels in adults with schizophrenia, overweight/obesity, and ...

The new class of anti-obesity drugs, glucagon-like peptide-1 receptor agonists (GLP-1RAs), is proving remarkably effective at ...